Reporting suspected adverse drug reactions

You can report a suspected adverse drug reaction (ADR) or a side effect from a medicine using our Yellow Card by clicking on the Yellow Card button below – this will take you to the online reporting site. Anybody from the United Kingdom can report this way.



Problem with postal delivery to the MHRA of completed Yellow Cards

We have identified a problem with the Yellow Card postal delivery service. Some Yellow Cards have been returned to sender due to an error at Royal Mail.

If you have posted a Yellow Card report form to us and have either had it returned or not received an acknowledgement letter, we kindly ask you to resend the report. This can be done by sending a new report form or reporting online at on the Yellow Card website.

The issue with Royal Mail has now been rectified and online reporting is unaffected.

We apologise for the inconvenience and appreciate your effort in reporting to the Yellow Card Scheme .


Go to the online reporting site for the Yellow Card Scheme
Go to the online reporting site for the Yellow Card Scheme
 (opens in a new window)


The Yellow Card Scheme is run by the MHRA and the Commission on Human Medicines (CHM), and is used to collect information from both health professionals and the general public on suspected side effects or ADRs to a medicine. Its continued success depends on the willingness of people to report suspected ADRs.

We collect Yellow Card reports from anyone from the UK on both licensed and unlicensed medicines including:

  • prescription medicines
  • over-the-counter (OTC) medicines
  • herbal remedies
  • cosmetic treatments

 

Campaign to encourage reporting of side effects to medicines… ‘Help make medicines safer for everyone’
We have launched a new, targeted campaign to increase public awareness of the Yellow Card Scheme. Yellow Card leaflets have been distributed to GP surgeries and pharmacies across the UK. This is supported by poster displays and the information video below, which encourages reporting to the scheme and is being shown in a number of GP surgery waiting rooms.

 

 

Reporting suspected side effects with a flu medicine (Tamiflu or Relenza) or vaccine (Pandemrix  or Celvapan)
Please report suspected ADRs to swine flu antiviral medicines (Tamiflu or Relenza) or vaccines (Pandemrix, made by GSK or Celvapan, made by Baxter) via the Swine Flu ADR Portal at https://swineflu.mhra.gov.uk

Swine flu - Report a side effect with a flu medicine

Information on suspected side effects to Tamiflu and Relenza
If you would like more information about the suspected side effects which have been reported to Tamiflu and Relenza to date, please visit our Swine Flu information pages.


Reporting incidents involving a defective medicine, medical device, blood reaction/event or suspected counterfeit product
If  you would like to report an adverse incident involving a medical device, an adverse blood reaction/event or a suspected counterfeit product, please use one of the methods described below:

Report an adverse incident (devices) bannerReport an adverse event or reaction (blood) bannerReport a counterfeit product banner

To report an incident involving a suspected defective medicine, please refer to the guidance in the following section:

Reporting suspected defects in medicines

Information for the pharmaceutical industry
Information for pharmaceutical companies on the reporting of suspected adverse drug reactions (ADRs) is available in the following section:

Reporting suspected adverse drug reactions: Information for the pharmaceutical industry 


Page last modified: 09 February 2010